NO20043547L - Aza-arylpiperaziner - Google Patents

Aza-arylpiperaziner

Info

Publication number: NO20043547L
Authority: NO; Norway
Prior art keywords: arylpiperazines; aza
Prior art date: 2002-01-29

Application number

NO20043547A

Other languages

English (en)

Norwegian (no)

Inventor

Paul Hebeisen

David Reginald Adams

Jonathan Mark Bentley

Jonathan Richard Anthon Roffey

Hans G F Richter

Toby Jonathan Blench

Nathaniel Julius Thomas Monck

Stephan Roever

Sven Taylor

Original Assignee

Vernalis Res Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-01-29

Filing date

2004-08-25

Publication date

2004-08-25

2004-08-25 Application filed by Vernalis Res Ltd filed Critical Vernalis Res Ltd

2004-08-25 Publication of NO20043547L publication Critical patent/NO20043547L/no

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Diabetes (AREA)
Psychiatry (AREA)
Hematology (AREA)
Obesity (AREA)
Endocrinology (AREA)
Addiction (AREA)
Pain & Pain Management (AREA)
Psychology (AREA)
Reproductive Health (AREA)
Heart & Thoracic Surgery (AREA)
Dermatology (AREA)
Hospice & Palliative Care (AREA)
Emergency Medicine (AREA)
Cardiology (AREA)
Gynecology & Obstetrics (AREA)
Child & Adolescent Psychology (AREA)
Anesthesiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Epoxy Compounds (AREA)
Hydrogenated Pyridines (AREA)

NO20043547A 2002-01-29 2004-08-25 Aza-arylpiperaziner NO20043547L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0202015.4A GB0202015D0 (en)	2002-01-29	2002-01-29	Piperazine Derivatives
PCT/EP2003/000459 WO2003064423A1 (en)	2002-01-29	2003-01-17	Aza-arylpiperazines

Publications (1)

Publication Number	Publication Date
NO20043547L true NO20043547L (no)	2004-08-25

Family

ID=9929954

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20043547A NO20043547L (no)	2002-01-29	2004-08-25	Aza-arylpiperaziner

Country Status (33)

Country	Link
US (1)	US7098337B2 (sr)
EP (1)	EP1472255B1 (sr)
JP (1)	JP4213042B2 (sr)
KR (1)	KR100644004B1 (sr)
CN (1)	CN1290847C (sr)
AR (1)	AR038237A1 (sr)
AT (1)	ATE318817T1 (sr)
AU (1)	AU2003205622B2 (sr)
BR (1)	BR0307291A (sr)
CA (1)	CA2472954C (sr)
DE (1)	DE60303791T2 (sr)
DK (1)	DK1472255T3 (sr)
EA (1)	EA200400881A1 (sr)
EC (1)	ECSP045208A (sr)
ES (1)	ES2259757T3 (sr)
GB (1)	GB0202015D0 (sr)
GT (1)	GT200300015A (sr)
HR (1)	HRP20040653A2 (sr)
IL (1)	IL162727A0 (sr)
MA (1)	MA27097A1 (sr)
MX (1)	MXPA04007147A (sr)
NO (1)	NO20043547L (sr)
PA (1)	PA8564001A1 (sr)
PE (1)	PE20030847A1 (sr)
PL (1)	PL371922A1 (sr)
PT (1)	PT1472255E (sr)
RS (1)	RS65704A (sr)
SI (1)	SI1472255T1 (sr)
TN (1)	TNSN04136A1 (sr)
TW (1)	TW200307683A (sr)
UY (1)	UY27627A1 (sr)
WO (1)	WO2003064423A1 (sr)
ZA (1)	ZA200405458B (sr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MXPA05012547A (es) *	2003-05-21	2006-05-25	Prosidion Ltd	Inhibidores de amida de acido pirrolopiridina-2-carboxilico de fosforilasa de glucogeno.
US7405210B2 (en)	2003-05-21	2008-07-29	Osi Pharmaceuticals, Inc.	Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase
GB0314967D0 (en) *	2003-06-26	2003-07-30	Hoffmann La Roche	Piperazine derivatives
AR046132A1 (es) *	2003-10-24	2005-11-23	Solvay Pharm Gmbh	Composicin farmaceutica que contiene al menos un compuesto con actividad de receptor de cb1, o un profarmaco , tautomero o sal del mismo, como componente activo adecuado para el tratamiento y/o profilaxis de enfermedades relacionadas con el receptor cb1 en pacientes juveniles y/o para el tratamiento
WO2005039579A1 (en) *	2003-10-24	2005-05-06	Solvay Pharmaceuticals Gmbh	Combination treatment of obesity involving selective cb1-antagonists and lipase inhibitors
US8685924B2 (en)	2004-08-25	2014-04-01	Takeda Pharmaceutical Company Limited	Preventives/remedies for stress urinary incontinence and method of screening the same
RU2007119315A (ru)	2004-10-25	2008-11-27	Зольвай Фармасьютиклз Гмбх (De)	Фармацевтические композиции, содержащие антагонисты каннабиноидного рецептора св1 и открыватели калиевых каналов, предназначенные для лечения сахарного диабета типа i, ожирения и связанных с ними состояний
KR100895758B1 (ko) *	2005-05-03	2009-04-30	에프. 호프만-라 로슈 아게	5-ｈｔ2 리간드로서 테트라사이클릭 아자피라지노인돌린
WO2006125179A1 (en) *	2005-05-19	2006-11-23	Xenon Pharmaceuticals Inc.	Tricyclic compounds and their uses as therapeutic agents
ES2351940T3 (es) *	2005-11-18	2011-02-14	F. Hoffmann-La Roche Ag	Derivados de azaindol-2-carboxamida.
US7579351B2 (en) *	2005-12-09	2009-08-25	Hoffmann-La Roche Inc.	Tricyclic amide derivatives
AU2006326067A1 (en)	2005-12-16	2007-06-21	F. Hoffmann-La Roche Ag	Pyrrolo [2 , 3-b] pyridine derivatives as H3 receptor modulators
EP2018863B9 (en)	2006-05-16	2015-02-18	Takeda Pharmaceutical Company Limited	Fused heterocyclic compound and use thereof
AU2007283113A1 (en)	2006-08-08	2008-02-14	Sanofi-Aventis	Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, processes for preparing them, medicaments comprising these compounds, and their use
EP2789338A3 (en)	2007-11-15	2015-01-14	Takeda Pharmaceutical Company Limited	Condensed pyridine derivate and use thereof
UY31968A (es)	2008-07-09	2010-01-29	Sanofi Aventis	Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos
WO2010068601A1 (en)	2008-12-08	2010-06-17	Sanofi-Aventis	A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
KR20120060207A (ko)	2009-08-26	2012-06-11	사노피	신규한 결정성 헤테로방향족 플루오로글리코시드 수화물, 이들 화합물을 포함하는 약제 및 이들의 용도
US20120253036A1 (en)	2009-12-11	2012-10-04	Yukinori Nagakura	Agent for treating fibromyalgia
FR2960876B1 (fr) *	2010-06-03	2012-07-27	Sanofi Aventis	Derives de 3,4-dihydropyrrolo[1,2-a]pyrazine-2,8(1h)-dicarboxamide leur preparation et leur application en therapeutique.
WO2012120058A1 (de)	2011-03-08	2012-09-13	Sanofi	Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
US8871758B2 (en)	2011-03-08	2014-10-28	Sanofi	Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
EP2683702B1 (de)	2011-03-08	2014-12-24	Sanofi	Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
EP2766349B1 (de)	2011-03-08	2016-06-01	Sanofi	Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
US8710050B2 (en)	2011-03-08	2014-04-29	Sanofi	Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
EP2683704B1 (de)	2011-03-08	2014-12-17	Sanofi	Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
US8828994B2 (en)	2011-03-08	2014-09-09	Sanofi	Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
EP2683703B1 (de)	2011-03-08	2015-05-27	Sanofi	Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
US8809325B2 (en)	2011-03-08	2014-08-19	Sanofi	Benzyl-oxathiazine derivatives substituted with adamantane and noradamantane, medicaments containing said compounds and use thereof
MY175254A (en) *	2012-04-26	2020-06-17	G1 Therapeutics Inc	Synthesis of lactams
AU2013301577B2 (en) *	2012-08-06	2017-03-30	F. Hoffmann-La Roche Ag	Piperazino[1,2-a]indol-1-ones and [1,4]diazepino[1,2-a]indol-1-one
WO2015066344A1 (en)	2013-11-01	2015-05-07	Arena Pharmaceuticals, Inc.	5-ht2c receptor agonists and compositions and methods of use
US10836764B2 (en) *	2016-08-19	2020-11-17	Arena Pharmaceuticals, Inc.	5-HT2C receptor agonists and compositions and methods of use
US20210052600A1 (en)	2017-12-27	2021-02-25	Takeda Pharmaceutical Company Limited	Therapeutic agents for stress urinary incontinence and incotinence of feces

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1247547A (en) *	1983-06-22	1988-12-28	Paul Hadvary	Leucine derivatives
CA1270837A (en) *	1984-12-21	1990-06-26	Hoffmann-La Roche Limited	Oxetanones
CA1328881C (en) *	1984-12-21	1994-04-26	Pierre Barbier	Process for the manufacture of oxetanones
CA2035972C (en)	1990-02-23	2006-07-11	Martin Karpf	Process for the preparation of oxetanones
US5274143A (en)	1991-07-23	1993-12-28	Hoffmann-La Roche Inc.	Process for the preparation of (R)-3-hexyl-5,6-dihydro-4-hydroxy-6-undecyl-2H-pyran-2-one and (R)-5,6-dihydro-6-undecyl-2H-pyran-2,4(3H)-dione
US6004996A (en) *	1997-02-05	1999-12-21	Hoffman-La Roche Inc.	Tetrahydrolipstatin containing compositions
US6267952B1 (en)	1998-01-09	2001-07-31	Geltex Pharmaceuticals, Inc.	Lipase inhibiting polymers
PT1105123E (pt)	1998-08-14	2004-08-31	Hoffmann La Roche	Composicoes farmaceuticas contendo inibidores da lipase e quitosano
CA2340056C (en)	1998-08-14	2007-01-09	F. Hoffmann-La Roche Ag	Pharmaceutical compositions containing lipase inhibitors
GB9902047D0 (en) *	1999-01-29	1999-03-17	Cerebrus Ltd	Chemical compounds XI
FR2799757B1 (fr) *	1999-10-15	2001-12-14	Adir	Nouveaux derives polycycliques azaindoliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

2002
- 2002-01-29 GB GBGB0202015.4A patent/GB0202015D0/en not_active Ceased
2003
- 2003-01-17 ES ES03702462T patent/ES2259757T3/es not_active Expired - Lifetime
- 2003-01-17 AU AU2003205622A patent/AU2003205622B2/en not_active Ceased
- 2003-01-17 DE DE60303791T patent/DE60303791T2/de not_active Expired - Lifetime
- 2003-01-17 JP JP2003564046A patent/JP4213042B2/ja not_active Expired - Fee Related
- 2003-01-17 WO PCT/EP2003/000459 patent/WO2003064423A1/en not_active Ceased
- 2003-01-17 PT PT03702462T patent/PT1472255E/pt unknown
- 2003-01-17 CN CNB03802943XA patent/CN1290847C/zh not_active Expired - Fee Related
- 2003-01-17 KR KR1020047011619A patent/KR100644004B1/ko not_active Expired - Fee Related
- 2003-01-17 RS YU65704A patent/RS65704A/sr unknown
- 2003-01-17 CA CA002472954A patent/CA2472954C/en not_active Expired - Fee Related
- 2003-01-17 BR BR0307291-6A patent/BR0307291A/pt not_active IP Right Cessation
- 2003-01-17 HR HR20040653A patent/HRP20040653A2/hr not_active Application Discontinuation
- 2003-01-17 AT AT03702462T patent/ATE318817T1/de active
- 2003-01-17 DK DK03702462T patent/DK1472255T3/da active
- 2003-01-17 PL PL03371922A patent/PL371922A1/xx not_active Application Discontinuation
- 2003-01-17 EA EA200400881A patent/EA200400881A1/ru unknown
- 2003-01-17 SI SI200330231T patent/SI1472255T1/sl unknown
- 2003-01-17 MX MXPA04007147A patent/MXPA04007147A/es unknown
- 2003-01-17 EP EP03702462A patent/EP1472255B1/en not_active Expired - Lifetime
- 2003-01-17 IL IL16272703A patent/IL162727A0/xx unknown
- 2003-01-24 PE PE2003000073A patent/PE20030847A1/es not_active Application Discontinuation
- 2003-01-24 US US10/350,616 patent/US7098337B2/en not_active Expired - Fee Related
- 2003-01-27 GT GT200300015A patent/GT200300015A/es unknown
- 2003-01-27 AR ARP030100229A patent/AR038237A1/es unknown
- 2003-01-28 PA PA20038564001A patent/PA8564001A1/es unknown
- 2003-01-28 UY UY27627A patent/UY27627A1/es not_active Application Discontinuation
- 2003-01-28 TW TW092101825A patent/TW200307683A/zh unknown
2004
- 2004-06-30 MA MA27756A patent/MA27097A1/fr unknown
- 2004-07-08 ZA ZA200405458A patent/ZA200405458B/en unknown
- 2004-07-22 TN TNP2004000136A patent/TNSN04136A1/en unknown
- 2004-07-27 EC EC2004005208A patent/ECSP045208A/es unknown
- 2004-08-25 NO NO20043547A patent/NO20043547L/no unknown

Also Published As

Publication number	Publication date
JP2005521671A (ja)	2005-07-21
DE60303791D1 (en)	2006-04-27
CN1625558A (zh)	2005-06-08
DE60303791T2 (de)	2006-11-02
IL162727A0 (en)	2005-11-20
TW200307683A (en)	2003-12-16
US20030207888A1 (en)	2003-11-06
CA2472954C (en)	2009-04-28
BR0307291A (pt)	2004-12-07
GB0202015D0 (en)	2002-03-13
TNSN04136A1 (en)	2007-03-12
WO2003064423A1 (en)	2003-08-07
EP1472255B1 (en)	2006-03-01
KR100644004B1 (ko)	2006-11-10
MXPA04007147A (es)	2004-10-29
CN1290847C (zh)	2006-12-20
AR038237A1 (es)	2005-01-05
PT1472255E (pt)	2006-06-30
PE20030847A1 (es)	2003-10-21
PA8564001A1 (es)	2003-09-05
GT200300015A (es)	2003-09-12
US7098337B2 (en)	2006-08-29
EP1472255A1 (en)	2004-11-03
ATE318817T1 (de)	2006-03-15
CA2472954A1 (en)	2003-08-07
UY27627A1 (es)	2003-07-31
RS65704A (sr)	2006-10-27
ZA200405458B (en)	2006-02-22
AU2003205622B2 (en)	2006-10-19
EA200400881A1 (ru)	2005-02-24
KR20040077885A (ko)	2004-09-07
ES2259757T3 (es)	2006-10-16
PL371922A1 (en)	2005-07-11
HRP20040653A2 (hr)	2005-06-30
DK1472255T3 (da)	2006-07-10
SI1472255T1 (sl)	2006-06-30
JP4213042B2 (ja)	2009-01-21
ECSP045208A (es)	2004-09-28
MA27097A1 (fr)	2004-12-20

Publication	Publication Date	Title
ATE457980T1 (de)	2010-03-15	Aryloxime
ATE534648T1 (de)	2011-12-15	C-6-modifizierte indazolylpyrrolotriazine
NO20044776L (no)	2004-12-07	Quinolinonderivater
DE50305852D1 (de)	2007-01-11	Einspritzventil
DE50306589D1 (de)	2007-04-05	Wischblatt
ATE427876T1 (de)	2009-04-15	Luftkissenboot
ATE318817T1 (de)	2006-03-15	Aza-arylpiperazine
DE50212360D1 (de)	2008-07-24	Anfahrhilfesteuerungsvorrichtung
DE50212349D1 (de)	2008-07-17	Hirurgie
DE50301200D1 (de)	2005-10-20	Wischblatt
ATE349458T1 (de)	2007-01-15	Etonogestrelester
DE50305301D1 (de)	2006-11-16	Einspritzventil
DE60328453D1 (de)	2009-09-03	Fahrzeugaufhängevorrichtung
DE50309536D1 (de)	2008-05-15	Fadenabsaugvorrichtung
DE50310481D1 (de)	2008-10-23	Röntgenstativ
DE50307971D1 (de)	2007-09-27	Gelenklager
DE50302660D1 (de)	2006-05-11	Stopfmachine
DE50301960D1 (de)	2006-01-26	Hydrolager
DE50309499D1 (de)	2008-05-08	Librierwerkzeugen
ATA4142004A (de)	2005-12-15	Trägerverbau
ATE469773T1 (de)	2010-06-15	Zugöse
DE50303317D1 (de)	2006-06-14	Einschub-leistungsschalter
DE50307628D1 (de)	2007-08-16	Getraenkehalter
ATA19152002A (de)	2004-11-15	Hubkupplung
DE50209283D1 (de)	2007-03-08	Tropfbewässerungsrohr